DAVIS, Calif., April 25, 2019 (GLOBE NEWSWIRE) --
Marrone Bio Innovations
Inc. (MBII) (MBI), an
international leader in smart biopesticide and plant health
solutions, will release financial results for the first quarter
ended March 31, 2019, after market close on Thursday, May 9,
2019.
Management will host an investor conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on May 9, 2019, to discuss Marrone Bio Innovations’ first quarter 2019 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information:
Q1 2019 Conference Call and
Webcast
Date: Thursday, May 9, 2019
Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern time)
U.S. Dial-in: 1-888-220-8474
International Dial-in: 1-323-794-2588
Conference ID: 9810931
Webcast: http://public.viavid.com/index.php?id=134326
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A playback of the call will be available through June 9, 2019. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally. Please use the replay pin number 9810931. A webcast will also be available for 30 days on the IR section of the Marrone Bio Innovations website or by clicking here: MBII Q1 2019 Webcast.
About Marrone Bio Innovations
Marrone Bio Innovations Inc. (MBII) strives to lead the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that support a better tomorrow for farmers, turf managers and consumers around the globe. MBI has screened more than 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes, enhanced by advanced molecular technologies, to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of more than 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus®, Amplitude™, Zelto® and Zequanox®. TerraConnect™ is MBI’s new seed treatment and soil-applied platform.
More information about Marrone Bio Innovations is available at www.marronebio.com. Follow MBI on social media: Twitter, Facebook, LinkedIn and Instagram.
Marrone Bio Innovations
Contacts:
Pam Marrone, CEO and Founder
Jim Boyd, CFO
Telephone: +1 (530) 750-2800
Email: [email protected]
Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
[email protected]